|
|  |
Volume 33, Number 3
© 2003 by the Journal of
Drug Issues
Online access is available to paid subscribers. Online content
is not to be distributed in digital form.
Introduction
to Special Issue on Safer Injection Facilities: Obstacles, Proposals,
Policies And Program Evaluations
Robert S. Broadhead
Supervised
Injection Facilities And International Law
Ian Malkin, Richard Elliott, Rowan Mcrae
The ongoing public health crisis associated with injection drug
use highlights the failure of prohibitionist policies. In contrast,
harm reduction approaches aim to protect and promote the health
of drug users. Supervised injection facilities (SIFs) are one
important component of this approach. This article considers the
international legal implications of establishing SIFs. It argues
that implementing trials of SIFs is an appropriate measure that
states should take pursuant to their international legal obligations
to realize progressively the right of their nationals to the highest
attainable standard of health. It argues that international drug
control treaties do not prevent such measures, as is commonly
claimed. The authors conclude that successful trials in Europe
and Australia should be emulated elsewhere, in accordance with
states' international obligations.
Responding
To An Explosive HIV Epidemic Driven By Frequent Cocaine Injection:
Is There A Role For Safe Injecting Facilities?
Thomas Kerr, Evan Wood,
Anita Palepu, Dean Wilson, Martin T. Schechter, Mark W. Tyndall
Although there have been repeated
calls for the establishment of safe injection facilities (SIFs)
in Vancouver since the early 1990s, questions remain concerning
the feasibility of SIFs due to the high prevalence of injection
cocaine and the concomitant problems cocaine use presents. Therefore,
we determined the prevalence of willingness to attend SIFs among
cocaine injectors in Vancouver and explored the factors associated
with this willingness, using data from the Vancouver Injection
Drug Users Study. After considering the results derived from this
analysis, additional qualitative methods were employed to explore
further willingness to use SIFs, barriers and facilitators of
uptake of SIFs, and methods of maximizing uptake among selected
subpopulations of cocaine injectors. The results suggest that
a high proportion of cocaine injectors, including some of those
most at risk, would attend an SIF if one were available. However,
in order to better accommodate cocaine injectors, several modifications
could be made to conventional SIF service design and delivery.
The vast majority of these modifications relate to ensuring effective
responses to cocaine toxicity. Given the acceptability of SIFs
among cocaine injectors, it appears that an SIF pilot could result
in significant and immediate benefits in terms of public health
and community safety.
The
Role Of Civil Disobedience In Drug Policy Reform: How An Illegal
"Safer Injection Room" Led To A Sanctioned, "Medically
Supervised Injection Center"
Alex Wodak, Ann Symonds,
Ray Richmond
In "Shooting Galleries,"
drug users are able to illegally rent cubicles to inject drugs.
Established in Kings Cross, Sydney in the early 1990s, police
grudgingly tolerated several such galleries. In 1997, a Royal
Commission recommended that a parliamentary enquiry consider establishing
an official medically supervised injecting centre (MSIC). Despite
strong evidence supporting MSIC, a majority of the committee voted
against a trial facility. As an act of civil disobedience, a group
of concerned citizens established an unsanctioned MSIC. However,
police soon closed the facility. At a subsequent Parliamentary
drug summit, delegates voted to support an official trial of an
MSIC and invited a congregation of Roman Catholic nuns to establish
the facility. When the nuns were instructed to withdraw, the Uniting
Church was invited to establish the project. The MSIC opened in
May 2001. It can be concluded that public health practitioners
wishing to improve appalling outcomes from drug policies sometimes
have to resort to civil disobedience in order to achieve their
goals.
The
Sydney Medically Supervised Injecting Centre: A Clinical Model
Ingrid van Beek
The Sydney Medically Supervised
Injecting Centre (MSIC) is the first supervised injecting facility
(SIF) in Australia and the English-speaking world. It commenced
operations in May 2001 as a trial to be independently evaluated.
The MSIC was to be the only SIF in Sydney's Kings Cross, a "red-light"
area where the drug-using population had previously injected in
public or in illegal "shooting galleries" that had proliferated
in nearby commercial sex premises since 1990. The aim of the MSIC
is to reduce the public health and public order issues arising
from unsupervised and public injecting at a local community level.
A clinical service model was developed, which would maximize the
number of injecting episodes accommodated in a professionally
supervised setting and integrate with the other harm reduction
services nearby. In its first two years of operation 4,719 registered
IDUs made 88,324 visits to inject at the MSIC. There were 553
drug overdoses (81% heroin) managed on site, with no fatalities.
Among 1,852 client referrals made for further assistance, 44%
were for the treatment of drug dependence. This early experience
suggests that the MSIC's clinical model has been acceptable to
a significant number of the street-based drug injecting population
in this setting.
Sydney
Medically Supervised Injecting Centre: Client Characteristics
And Predictors Of Frequent Attendance During The First 12 Months
Of Operation
Jo Kimber, Margaret Macdonald,
Ingrid Van Beek, John Kaldor, Don Weatherburn, Helen Lapsley,
Richard P. Mattick
This paper describes characteristics
of clients registered in the first 12 months of the Sydney Medically
Supervised Injecting Centre’s (MSIC) operation, as well
as predictors of frequent attendance. The study is based on information
collected from clients at their initial registration and subsequent
service utilization. Most of the 2,719 clients were male (71%),
almost half had previously experienced at least one nonfatal heroin
overdose, and one quarter had accessed formal drug treatment in
the previous 12 months. Characteristics associated with frequent
attendance at the MSIC were reporting previous attendance at the
local primary health service for injecting drug users (IDU), injecting
drugs other than amphetamine, reporting sex work, injecting at
least daily, and injection in a public place in the month before
registration. The large number of registrations and return visits
suggests there is demand for a service of this kind in the study
area and that the MSIC is being utilized by high-risk IDU subpopulations.
Drug
Consumption Facilities In The Netherlands
Judith Wolf, Loes Linssen
And Ireen De Graaf
Drug users in many Dutch cities
are no longer condemned to use their drugs in abandoned alleys,
dark doorways or the toilets of drop-in centers. In recent years,
special drug consumption facilities have been created where hard-drug
users can administer their drugs in relative peace and quiet.
At the time of this writing, more than 20 such drug consumption
facilities are now operating in nine Dutch cities – Amsterdam,
Apeldoorn, Arnhem, Den Bosch, Groningen, Heerlen, Maastricht,
Rotterdam and Venlo. Other cities, including Utrecht, Flushing,
The Hague, Zwolle, Nijmegen, and Alkmaar, are keenly debating
whether to open such venues in their cities. The notable emergence
of drug consumption facilities in the 1990s coincided with national
and local efforts to curb the nuisance caused by drug users. The
assumption has been that such facilities play a significant role
in combating this nuisance (Nota Overlast, 1993; Broër &
Noyon, 1999). However, curbing nuisance is not the only perceived
benefit of the facilities. Social addiction care programs also
attach great importance to low-threshold care services, including
drug consumption facilities, as part of their effort to improve
the care provision to long-term drug addicts and to encourage
the safer use of drugs. Now that the first drug consumption facilities
have been in operation for several years, it is interesting to
investigate how such services exactly work, how the facilities
differ from one another, and what aspects of these facilities
may need improvement. These were the key questions in a practical
study we conducted on drug consumption facilities from October
2000 to March 2001. Along with this exploratory research, we also
conducted a literature review on drug consumption facilities that
was commissioned by the Social Addiction Policy Development Centre
(Linssen, de Jong, & Wolf, 2001). Later, in the practical
study, we visited a total of 13 facilities1, interviewed their
staff and clients, performed observations and carried out a telephone
survey of all 21 facilities (18 of which responded). This article
reports our findings on the actual functioning of the drug consumption
facilities. Data relating to the setting-up phase of drug-consumption
facilities is not addressed in this report.
Drug
Consumption Rooms In Hamburg, Germany: Evaluation Of The Effects
On Harm Reduction And The Reduction Of Public Nuisance
Heike Zurhold, Peter Degkwitz,
Uwe Verthein, Christian Haasen
In order to evaluate the impact
of consumption rooms (CRs) on the promotion of health among drug
users and the reduction of the public nuisance of drug use, a
study examining CRs in three countries was carried out in 2000.
The study, supported by the European Commission, examined CRs
in Rotterdam (The Netherlands), Innsbruck (Austria), and Hamburg
(Germany). This paper evaluates the findings from the study of
Hamburg CRs. In order to get evidence-based information on the
effects of CRs, 616 drug users in the Hamburg drug scene or in
the vicinity of low-threshold institutions were investigated with
a standardized questionnaire. Qualitative problem-centered interviews
were also carried out with staff members of the CRs, and representatives
from the community, including neighborhood residents, business
people, police, and politicians. Research findings show that the
Hamburg CRs reached the target group of drug users who practice
risky behaviors and engage in public drug use. Findings also show
that the Hamburg CRs lead to positive changes in health-related
behavior for drug users. In addition, the findings indicate that
the Hamburg CRs played an important role in the reduction of public
disturbances in the vicinity of open drug scenes.
Barcelona’s
Safer Injection Facility - Eva: A Harm Reduction Program Lacking
Official Support
Manel Anoro, Enrique Ilundain, Oscar Santisteban
EVA – Espacio de Venopunción
higiénica Asistida – is the first safe injection
facility (SIF) in Barcelona, Spain. Started on September 12, 2001,
it began as a “poor relative” of DAVE –Dispositivo
Asistencial de Venopunción – in Madrid. EVA suffers
from the general underfunding of its parent program, the Can Tunis
outreach program, and it has no formal or material support from
municipal authorities. This SIF can accommodate five drug injectors
at one time and also operates as a mobile room for shelter, contact,
and health education, addressing mainly those drug users who are
at highest risk of overdose, HIV infection, violence, and death.
The project offers consistent services provided by an array of
health care and welfare professionals, and it is ready to intervene
in overdose and/or crisis situations. To date, it has an excellent
record in providing a safe environment for both its staff of health
care professionals and its clients. Below the Can Tunis area in
general, the outreach program, and EVA are described. The advantages,
disadvantages, and what has been learned from working in this
quarter of Barcelona with the injection drug using community is
discussed. In closing, questions and proposals for future efforts
are addressed.
Ascertaining
The Need For A Supervised Injecting Facility (SIF): The Burden
Of Public Injecting In Montreal, Canada
Traci Green, Catherine Hankins,
Darlène Palmer, Jean-François Boivin, Robert Platt
Empirical evidence suggests
that a key prerequisite for a supervised injection facility (SIF)
utilization is the existence of an "open drug scene,"
where users publicly inject drugs. This study seeks to determine
the extent and profile of public injecting among injecting drug
users (IDUs) in Montreal, Canada, where pilot SIFs are under consideration.
A cross-sectional study of IDUs who injected publicly at least
once in the previous month was appended to an HIV-risk surveillance
study among Montreal IDUs (SurvUDI study). Of 650 SurvUDI participants
interviewed between June 2001 and February 2002, 59% were eligible.
A dose-response relationship emerged between intensity of public
injecting and several drug-use and risk-related characteristics.
Regardless of housing stability, IDUs persistently and, often
preferably, publicly injected due to habit, dependence, or need
to conceal their status. Despite lacking a classical open drug
scene, public injecting is common among Montreal IDUs, warranting
the consideration of an SIF for this population.
Safer
Injection Sites in New York City: A Utilization Survey of Injection
Drug Users
Robert S. Broadhead, Casey
A. Borch, Yael van Hulst, Jason Farrell, Wayne J. Villemez, Frederick
L. Altice
HIV, hepatitis B & C, drug
overdose, and other drug-related health problems still pose significant
health risks to injection drug users (IDUs) and their sexual partners,
indicating the need for further development of innovative public
health interventions. A relatively new intervention implemented
in many municipalities throughout the world is the “safer
injection site” (SIS). An SIS is a legal facility that allows
people to prepare and inject pre-obtained drugs in a hygienic,
anxiety-free atmosphere under the supervision of health personnel.
This paper examines the responses of a sample of IDUs in New York
City to whether they would use an SIS should one be implemented
in mid-town Manhattan. The SIS would be part of a comprehensive
harm reduction project that already offers needle-exchange, street
outreach, testing and counseling, support groups, referral services
including drug treatment, and on-site primary medical and dental
services. The results of our study indicate that a large majority
of the IDUs sampled would utilize an SIS should one be implemented,
and that those most likely to use it are IDUs at the highest risk
for contracting or spreading blood-borne diseases such as HIV
and hepatitis, and for experiencing a drug overdose.
Shooting
Gallery Users and HIV Risk
Hugh Klein, Judith A. Levy
Recognizing that HIV transmission
occurs within situated interactions between two or more people,
prevention research has increasingly begun to focus on identifying
the influence of situations and settings on the spread of HIV.
Examination of the social geography of risk has emerged as a powerful
tool for understanding where and among whom risky practices occur.
In this regard, shooting galleries represent interactional territories
where the normative expectations of participation within their
spatial boundaries can both encourage and reinforce sex and drug-related
risky behavior. Indeed, research shows that those who inject in
shooting galleries tend to be at a higher risk of transmitting
HIV than those who inject elsewhere. Drawing upon data from a
sample of 1,113 active injecting drug users, we examined the demographic
and psychosocial factors that predict shooting gallery use. Next,
we compared shooting gallery users with nonusers in terms of drug
use, followed by an examination of differences in sex and drug-related
HIV risk behaviors. Then, we explored preventive practices that
possibly differentiate those who use shooting galleries from those
who do not. We end our analysis by discussing the implications
of our results for HIV prevention and social policy.
|
 |